These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 9121510)

  • 1. Reversible severe myopathy during treatment with finasteride.
    Haan J; Hollander JM; van Duinen SG; Saxena PR; Wintzen AR
    Muscle Nerve; 1997 Apr; 20(4):502-4. PubMed ID: 9121510
    [No Abstract]   [Full Text] [Related]  

  • 2. Finasteride in benign prostatic hyperplasia.
    Wysowski DK; Farinas E
    N Engl J Med; 2004 Mar; 350(13):1359-61; author reply 1359-61. PubMed ID: 15044649
    [No Abstract]   [Full Text] [Related]  

  • 3. Analyzing finasteride data.
    Frankel S
    Neurourol Urodyn; 1995; 14(6):619-24. PubMed ID: 8750380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The safety of finasteride used in benign prostatic hypertrophy: a non-interventional observational cohort study in 14,772 patients.
    Wilton L; Pearce G; Edet E; Freemantle S; Stephens MD; Mann RD
    Br J Urol; 1996 Sep; 78(3):379-84. PubMed ID: 8881946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term (7 to 8-year) experience with finasteride in men with benign prostatic hyperplasia.
    Vaughan D; Imperato-McGinley J; McConnell J; Matsumoto AM; Bracken B; Roy J; Sullivan M; Pappas F; Cook T; Daurio C; Meehan A; Stoner E; Waldstreicher J
    Urology; 2002 Dec; 60(6):1040-4. PubMed ID: 12475666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Proscar (finasteride, MSD) in the treatment of patients with prostatic hyperplasia].
    Pytel' IuA; Vinarov AZ
    Urol Nefrol (Mosk); 1996; (4):25-7. PubMed ID: 8928344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Finasteride induced gynecomastia.
    Carlin BI; Seftel AD; Resnick MI; Findlay J
    J Urol; 1997 Aug; 158(2):547. PubMed ID: 9224349
    [No Abstract]   [Full Text] [Related]  

  • 8. Finasteride-induced thrombocytopenia.
    Kouriefs C; Betambeau N; Rowbotham C; Coyne K; Rowley M; Jones CR
    BJU Int; 2002 Aug; 90(3):348-9. PubMed ID: 12133077
    [No Abstract]   [Full Text] [Related]  

  • 9. [Benign prostatic hyperplasia. Finasteride controls progression of BPH].
    MMW Fortschr Med; 2000 Jun; 142(25):62-3. PubMed ID: 10920676
    [No Abstract]   [Full Text] [Related]  

  • 10. [Comparative evaluation of the effectiveness and safety of combined drug therapy of patients with benign prostatic hyperplasia with finasteride and alfuzozine].
    Loran OB; Pushkar' DIu; Rasner PI
    Urologiia; 2002; (1):19-22. PubMed ID: 11877966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia. Finasteride Long-Term Efficacy and Safety Study Group.
    McConnell JD; Bruskewitz R; Walsh P; Andriole G; Lieber M; Holtgrewe HL; Albertsen P; Roehrborn CG; Nickel JC; Wang DZ; Taylor AM; Waldstreicher J
    N Engl J Med; 1998 Feb; 338(9):557-63. PubMed ID: 9475762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benign prostatic hyperplasia: natural history, endocrine pathogenesis, and medical treatment with finasteride.
    Sherwood LM
    Mt Sinai J Med; 1996 Jan; 63(1):1-9. PubMed ID: 8935843
    [No Abstract]   [Full Text] [Related]  

  • 13. Finasteride: a steroid-unsparing drug?
    Persey M; Payne L; Webley M
    Rheumatology (Oxford); 1999 Mar; 38(3):285. PubMed ID: 10325672
    [No Abstract]   [Full Text] [Related]  

  • 14. [Efficacy and safety of doxazosine in combination with finasteride in the treatment of prostatic adenoma].
    Bogdanov AB; Luk'ianov IV; Veliev EI
    Urologiia; 2008; (6):44-9. PubMed ID: 19248599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urticarial rush due to finasteride.
    Moreno-Fernandez A; Mira Laguarda JM; Ruiz-Hornillos FJ; Rubio Sotes M
    Allergy; 2010 Mar; 65(3):405-6. PubMed ID: 19814757
    [No Abstract]   [Full Text] [Related]  

  • 16. Finasteride: new indication. Benign prostatic hypertrophy: sexual disorders.
    Prescrire Int; 2007 Aug; 16(90):147. PubMed ID: 17724838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapy of benign prostatic hyperplasia: terazosin or finasteride?].
    Trinkler FB
    Praxis (Bern 1994); 1997 Aug; 86(34):1305-6. PubMed ID: 9381019
    [No Abstract]   [Full Text] [Related]  

  • 18. 5-Alpha reductase inhibitors and risk of hip fracture.
    Bollu M; Marte-Grau AC; Bobba RK
    JAMA; 2009 Mar; 301(9):935; author reply 935. PubMed ID: 19258583
    [No Abstract]   [Full Text] [Related]  

  • 19. Intraoperative floppy-iris syndrome and finasteride intake.
    Issa SA; Dagres E
    J Cataract Refract Surg; 2007 Dec; 33(12):2142-3. PubMed ID: 18053919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Finasteride for BPH.
    Johnson KH; Casey CM
    J Fam Pract; 1998 Jun; 46(6):455-6. PubMed ID: 9638104
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.